Rafa Laboratories Workers Declare Labor Dispute Less Than a Month After IPO
How 2 Israeli newsrooms covered this story — translated into English and compared side by side.
First reported by Calcalist · 3 hours ago
What happened
Employees of Rafa Laboratories have declared a labor dispute less than a month after the company's IPO on the Tel Aviv Stock Exchange, claiming they were not compensated for the offering. The dispute has led to operational disruptions at the Jerusalem factory. Rafa, a longstanding pharmaceutical firm with a significant bio-defense division, reported stable financial results for 2025 and is currently evaluating how to address the labor actions.
- 01Rafa Laboratories employees declare labor dispute over IPO compensation less than a month after listing.
- 02Workers have begun disrupting operations at the Jerusalem factory as part of their protest.
- 03Rafa completed an IPO valuing the company at 1.55 billion shekels last month.
- 04The company reported stable 2025 revenues of 418 million shekels and net profit of about 100 million shekels.
- 05Rafa develops over 100 pharmaceutical products and operates a growing bio-defense segment.
- 06Management states ongoing direct talks with employees and is assessing the labor actions' legality and impact.
Summary translated & synthesized from the sources below by baba. Read each original for the full report.
Full coverage · 2 outlets
The same event, reported separately by each newsroom. Open a few to compare what each emphasizes — and what they leave out.
